Clinical trial
Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With…
NCT00099086 · Medical University of South Carolina, Other · Completed
Key facts
| NCT number | NCT00099086 |
|---|---|
| Title | Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer |
| Official title | Phase I Trial of Concurrent Taxotere With Radiation Therapy and Hormonal Therapy For Clinically Localized High Risk Prostate Cancer |
| Lead sponsor | Medical University of South Carolina, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug, Radiation |
| Interventions | Bicalutamide, docetaxel, GnRh analog, radiotherapy |
| Enrollment | 20 |
| Start date | Jan 16, 2007 |
| Primary completion | Jan 20, 2011 |
| Completion | Dec 13, 2023 |
| First posted | Dec 9, 2004 |
| Last update posted | Jan 31, 2024 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: